NewAmsterdam Pharma Company N.V. Analysis
| Analyst Ratings |
|
Average Target Price
|
25.16
|
|
Average Rating
|
4.56
|
|
# Strong Buys
|
5
|
|
# Buys
|
4
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2024-09-30
|
-0.50
|
-0.18
|
0.32
|
64.00%
|
|
2024-06-30
|
-0.58
|
-0.41
|
0.17
|
29.31%
|
|
2024-03-31
|
-0.53
|
-1.06
|
-0.53
|
-100.00%
|
|
2023-12-31
|
-0.55
|
-0.54
|
0.01
|
1.82%
|
|
2023-09-30
|
-0.87
|
-0.56
|
0.31
|
35.38%
|
|
2023-06-30
|
-0.42
|
-1.01
|
-0.59
|
-140.48%
|
|
2023-03-31
|
-0.42
|
-0.44
|
-0.01
|
-2.69%
|
|
2022-12-31
|
-0.49
|
-1.80
|
-1.31
|
-267.35%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2024-09-30
|
-1.65
|
|
2023-12-31
|
-2.55
|
|
2022-12-31
|
-2.06
|
|
2021-12-31
|
0.24
|